SK Capital has entered exclusive negotiations to acquire Lisi Medical, a leading MedTech CDMO, to accelerate its growth and expand capabilities.
Overview of the Target
Lisi Medical is a prominent contract development and manufacturing organization (CDMO) in the MedTech sector, specializing in the creation of high-precision metal components and assemblies tailored for global medical device original equipment manufacturers (OEMs). The company’s product offerings include instruments designed for minimally invasive and robotic-assisted surgical procedures, along with orthopedic implants. Lisi Medical operates four manufacturing facilities, leveraging expertise in precision machining, forging, and engineering, with two located in Minnesota, USA, and the other two in France.
Industry Overview in France
The MedTech industry in France has seen significant growth over the past decade, driven by technological advancements and the rising demand for innovative healthcare solutions. France is recognized as a key player in the European healthcare landscape, home to a well-established ecosystem of medical device manufacturers, research institutions, and supportive government policies that foster innovation.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
France's emphasis on quality and regulatory compliance has resulted in a robust framework for medical device safety and efficacy, providing a reliable market for manufacturers like Lisi Medical. Moreo
Similar Deals
General Atlantic → Legent Health
2025
ChristianaCare → Crozer Health outpatient locations
2025
Prime Healthcare → Ascension facilities
2025
Gallant Capital Partners, LLC → Aero Turbine, Inc.
2025
Bain Capital → HealthEdge and UST HealthProof
2025
SK Capital
invested in
LISI Group Medical division
in 2025
in a Other Private Equity deal